Lazard Asset Management LLC Vor Biopharma Inc. Transaction History

Lazard Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.0 - $2.2 $1,441 - $3,170	-1,441 Reduced 95.68%	65 $0
Q1 2024 May 14, 2024	SELL	$1.8 - $2.85 $1,027 - $1,627	-571 Reduced 27.49%	1,506 $3,000
Q4 2023 Feb 14, 2024	SELL	$1.66 - $2.63 $147 - $234	-89 Reduced 4.11%	2,077 $4,000
Q3 2023 Nov 14, 2023	BUY	$2.1 - $3.35 $178 - $284	85 Added 4.08%	2,166 $4,000
Q2 2023 Aug 14, 2023	BUY	$3.09 - $5.33 $228 - $394	74 Added 3.69%	2,081 $6,000
Q1 2023 May 15, 2023	BUY	$4.68 - $6.96 $1,839 - $2,735	393 Added 24.35%	2,007 $10,000
Q4 2022 Feb 14, 2023	BUY	$3.77 - $7.43 $6,084 - $11,992	1,614 New	1,614 $10,000

41.2M

9.3K

100

Ticker VOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,056,300
Market Cap $32.7M
Description
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lazard Asset Management LLC with notifications on news.